Parallel Advisors, LLC Procept Bio Robotics Corp Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,010 shares of PRCT stock, worth $34,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,010
Previous 1,020
0.98%
Holding current value
$34,279
Previous $61,000
4.92%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
290Shares Held
44MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$178 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$118 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$73.2 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$51.9 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$44.9 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.51B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...